Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-12-09 9:33 pm Unchanged |
2024-12-05 | 13D | Lexicon Pharmaceuticals, Inc. LXRX |
Invus L.P. | 136,180,481 37.700% |
0 (Unchanged) |
Filing History |
2024-07-29 5:44 pm Sale |
2024-07-25 | 13D | Lexicon Pharmaceuticals, Inc. LXRX |
Invus L.P. | 136,180,481 37.700% |
-38,918,903![]() (-22.23%) |
Filing History |
2024-05-14 5:05 pm Purchase |
2024-05-10 | 13D | Lexicon Pharmaceuticals, Inc. LXRX |
Invus L.P. | 175,099,384 48.400% |
57,546,100![]() (+48.95%) |
Filing History |
2024-03-13 9:20 pm Unchanged |
2024-03-11 | 13D | Lexicon Pharmaceuticals, Inc. LXRX |
Invus L.P. | 117,553,284 47.700% |
0 (Unchanged) |
Filing History |
2023-06-05 5:48 pm Purchase |
2023-05-31 | 13D | Lexicon Pharmaceuticals, Inc. LXRX |
Invus L.P. | 117,553,284 48.000% |
27,775,050![]() (+30.94%) |
Filing History |
2022-08-09 4:31 pm Purchase |
2022-08-05 | 13D | Lexicon Pharmaceuticals, Inc. LXRX |
Invus L.P. | 89,778,234 47.600% |
2,426,070![]() (+2.78%) |
Filing History |
2022-08-01 4:16 pm Purchase |
2022-07-27 | 13D | Lexicon Pharmaceuticals, Inc. LXRX |
Invus L.P. | 87,352,164 47.600% |
16,173,800![]() (+22.72%) |
Filing History |
2021-01-21 4:57 pm Unchanged |
2021-01-11 | 13D | Lexicon Pharmaceuticals, Inc. LXRX |
Invus L.P. | 71,178,364 50.300% |
0 (Unchanged) |
Filing History |
2021-01-05 5:26 pm Unchanged |
2020-12-31 | 13D | Lexicon Pharmaceuticals, Inc. LXRX |
Invus L.P. | 71,178,364 50.300% |
0 (Unchanged) |
Filing History |
2020-12-16 4:40 pm Purchase |
2020-12-11 | 13D | Lexicon Pharmaceuticals, Inc. LXRX |
Invus L.P. | 71,178,364 50.300% |
10,937,500![]() (+18.16%) |
Filing History |